https://www.rezera.com/press-release/nodthera-announces-late-breaking-oral-presentation-at-the-94th-eas-congress/ 2026-08-11T14:50:54+00:00 https://www.rezera.com/press-release/nodthera-announces-appointment-of-elisabeth-bjork-as-board-member/ 2026-08-11T15:08:40+00:00 https://www.rezera.com/press-release/nodthera-charts-obesity-future-with-first-patients-dosed-in-phase-2-resolve-1-trial-of-oral-nlrp3-inflammasome-inhibitor-nt-0796/ 2026-08-11T15:09:28+00:00 https://www.rezera.com/press-release/nodthera-announces-appointment-of-dr-jyothis-george-as-chief-medical-officer/ 2026-08-11T15:11:40+00:00 https://www.rezera.com/press-release/nodthera-demonstrates-reversal-of-neuroinflammation-and-inflammation-in-parkinsons-disease-with-oral-nlrp3-inhibitor/ 2026-08-11T15:14:02+00:00 https://www.rezera.com/press-release/nodthera-announces-first-patients-dosed-in-resolve-2-clinical-trial-evaluating-oral-nt-0796-in-combination-with-a-glp-1-receptor-agonist/ 2026-08-11T15:16:17+00:00 https://www.rezera.com/press-release/nodthera-announces-appointment-of-chris-guiffre-j-d-m-b-a-as-chief-financial-officer/ 2026-08-11T15:24:12+00:00 https://www.rezera.com/press-release/nodthera-appoints-geoff-mcdonough-m-d-as-independent-board-member/ 2026-08-11T15:27:49+00:00 https://www.rezera.com/press-release/nodthera-announces-presentation-at-the-44th-annual-j-p-morgan-healthcare-conference/ 2026-08-11T15:32:36+00:00 https://www.rezera.com/press-release/nodthera-appoints-geoff-mcdonough-m-d-as-chief-executive-officer/ 2026-08-11T15:35:36+00:00 https://www.rezera.com/press-release/nodthera-to-present-at-oppenheimer-36th-annual-healthcare-life-sciences-conference/ 2026-08-11T15:38:29+00:00 https://www.rezera.com/press-release/nodthera-to-participate-in-april-investor-conferences/ 2026-08-11T15:44:44+00:00 https://www.rezera.com/press-release/nodthera-announces-late-breaking-oral-presentation-at-the-94th-eas-congress-2/ 2026-08-11T15:46:37+00:00 https://www.rezera.com/press-release/nodthera-announces-the-publication-and-presentation-of-cardiometabolic-clinical-data-supporting-the-potential-of-ruvonoflast-to-treat-inflammation-at-the-source/ 2026-09-03T01:27:52+00:00 https://www.rezera.com/press-release/nodthera-to-participate-in-cantor-global-healthcare-conference/ 2026-09-03T21:28:44+00:00 https://www.rezera.com/press-release/rezera-announces-ruvonoflast-met-its-primary-inflammation-endpoint-and-demonstrated-favorable-safety-profile-in-resolve-1-phase-2-clinical-trial/ 2026-09-09T08:01:03+00:00 https://www.rezera.com/press-release/nodthera-inc-changes-name-to-rezera-inc-and-announces-ruvonoflast-phase-3-development-program/ 2026-09-09T08:00:34+00:00